Radiolabeling, stability, and body distribution in rats, of low molecular weight polylactide homopolymer and polylactide-polyethyleneglycol copolymer

Biomaterials

Volumn 21, Issue 2, 2000, Pages 199-209

  Bridges, Janine F ^a   Critchlow, Margaret ^a   P Irving, Michael ^b   Purkiss, Stuart C ^b   Taylor, David C ^b   Lloyd, John B ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b S   (United Kingdom)

Author keywords

125I labeling; Polylactide; Polylactide polyethyleneglycol copolymer; Tissue distribution

Indexed keywords

CARBOXYLIC ACIDS; COPOLYMERS; MOLECULAR WEIGHT; POLYESTERS; POLYETHYLENE GLYCOLS; RADIOACTIVITY; SYNTHESIS (CHEMICAL); TISSUE;

POLYLACTIDE; RADIOLABELING;

BIOMATERIALS;

COPOLYMER; MACROGOL; POLYLACTIDE;

ANIMAL EXPERIMENT; ARTICLE; ISOTOPE LABELING; MOLECULAR STABILITY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0033991540     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00172-6     Document Type: Article

References (13)

1. Hutchinson F.G., Furr B.J.A. Design of biodegradable polymers for controlled release. Johnson P., Lloyd-Jones J.G. Drug delivery systems. fundamentals and techniques:1987;106-119 Chichester, Ellis Horwood.
2. Gogolewski S., Jovanovic M., Perren S.M., Dillon J.G., Hughes M.K. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 27:1993;1135-1148.
3. Miyamoto S., Takaoka K., Okada Tet al. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin Orthop. 278:1992;274-285.
4. Tabata Y., Takebayashi Y., Ueda T., Ikada Y. A formulation method using D,L-lactic acid oligomer for protein release with reduced initial burst. J Controlled Release. 23:1993;55-64.
5. Wichert B, Rohdewald P. Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles? J Microencapsulation 1993;10:195-207.
6. Miyamoto S., Takaoka K., Okada T.et al. Poplylactic acid-polyethylene glycol block copolymer. Clin Orthop. 294:1993;333-343.
7. Stolnik S., Dunn S.E., Garnett M.C., Davies M.C., Coombes A.G.A., Taylor D.C., Irving M.P., Purkiss S.C., Tadros T.F., Davis S.S., Illum L. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethyleneglycol) copolymers. Pharm Res. 11:1994;1800-1808.
8. Von Burkersroda F, Gref R, Göpferich A. Erosion of biodegradable block copolymers made of poly(D,L-lactic acid) and poly(ethylene glycol). Biomaterials 18:1599-607.
9. Gref R., Minamitake Y, Peracchia MT, Trubetskoy V, Torchillin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1603.
10. Kwon G.S., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Biodistribution of micelle-forming polymer-drug conjugates. Pharm Res. 10:1993;970-974.
11. Nathan A., Zalipsky S., Ertel S.I., Agathos S.N., Yarmush M.L., Kohn J. Copolymers of lysine and polyethylene glycol. a new family of functionalized drug carriers Bioconj Chem. 4:1993;54-62.
12. Putnam D., Kopecek J. Polymer conjugates with anticancer activity. Adv Polymer Sci. 122:1995;55-123.
13. Duncan R., Dimitrijevic S., Evagorou E.G. The role of polymer conjugates in the diagnosis and treatment of cancer. STP Pharm Sci. 6:1996;237-263.